Sk Biopharmaceutica (Korea) Price on November 26, 2024
| 326030 Stock | 106,300 1,100 1.05% |
If you're considering investing in 326030 Stock, it is important to understand the factors that can impact its price. As of today, the current price of Sk Biopharmaceutica stands at 106,300, as last reported on the 19th of December, with the highest price reaching 107,600 and the lowest price hitting 104,300 during the day. At this point, Sk Biopharmaceutica is very steady. Sk Biopharmaceuticals retains Efficiency (Sharpe Ratio) of 0.0015, which indicates the firm had a 0.0015% return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for Sk Biopharmaceutica, which you can use to evaluate the volatility of the company. Please validate Sk Biopharmaceutica's Downside Deviation of 2.64, mean deviation of 2.27, and Risk Adjusted Performance of 0.0277 to confirm if the risk estimate we provide is consistent with the expected return of 0.0044%.
326030 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
326030 |
Sharpe Ratio = 0.0015
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 326030 |
Estimated Market Risk
| 2.93 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sk Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sk Biopharmaceutica by adding Sk Biopharmaceutica to a well-diversified portfolio.
Sk Biopharmaceutica Valuation on November 26, 2024
It is possible to determine the worth of Sk Biopharmaceutica on a given historical date. On November 26, 2024 326030 was worth 100900.0 at the beginning of the trading date compared to the closed value of 97700.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sk Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find Sk Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sk Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sk Biopharmaceutica's related companies.
| Open | High | Low | Close | Volume | |
| 96,500 | 101,400 | 95,400 | 100,900 | 404,496 | |
11/26/2024 | 100,900 | 101,800 | 96,700 | 97,700 | 226,710 |
| 97,700 | 100,000 | 97,100 | 99,900 | 193,584 |
| Backtest Sk Biopharmaceutica | | | Sk Biopharmaceutica History | | | Sk Biopharmaceutica Valuation | Previous | Next |
Sk Biopharmaceutica Trading Date Momentum on November 26, 2024
| On November 27 2024 Sk Biopharmaceuticals Co was traded for 99,900 at the closing time. The highest price during the trading period was 100,000 and the lowest recorded bid was listed for 97,100 . The volume for the day was 193.6 K. This history from November 27, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 2.25% . The trading price change to the current price is 6.76% . |
Sk Biopharmaceuticals Fundamentals Correlations and Trends
By evaluating Sk Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sk Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. 326030 financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sk Biopharmaceutica Stock history
Sk Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 326030 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sk Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sk Biopharmaceutica stock prices may prove useful in developing a viable investing in Sk Biopharmaceutica
Sk Biopharmaceutica Stock Technical Analysis
Sk Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sk Biopharmaceutica Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Sk Biopharmaceuticals Co cannot be verified against its exchange. Please verify the symbol is currently traded on Korea Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sk Biopharmaceutica December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Sk Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sk Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Sk Biopharmaceutica stock market strength indicators, traders can identify Sk Biopharmaceuticals Co entry and exit signals to maximize returns
Sk Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sk Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of 326030 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of 326030 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0277 | |||
| Jensen Alpha | 0.0629 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0176 | |||
| Treynor Ratio | 0.4962 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for 326030 Stock analysis
When running Sk Biopharmaceutica's price analysis, check to measure Sk Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sk Biopharmaceutica is operating at the current time. Most of Sk Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sk Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sk Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sk Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |